COVID‐19 vaccine side effects among nursing home residents and staff

This publication has 9 references indexed in Scilit:

• Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions — United States, March–August 2021
  MMWR. Morbidity and Mortality Weekly Report, 2021
• Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant — National Healthcare Safety Network, March 1–August 1, 2021
  MMWR. Morbidity and Mortality Weekly Report, 2021
• Effectiveness of COVID-19 Vaccines in Preventing Hospitalization Among Adults Aged ≥65 Years — COVID-NET, 13 States, February–April 2021
  MMWR. Morbidity and Mortality Weekly Report, 2021
• Adverse events following mRNA SARS-CoV-2 vaccination among U.S. nursing home residents
  Vaccine, 2021
• Non‐life‐threatening adverse effects with COVID‐19 mRNA‐1273 vaccine: A randomized, cross‐sectional study on healthcare workers with detailed self‐reported symptoms
  Journal of Medical Virology, 2021
• Management of anaphylaxis due to COVID‐19 vaccines in the elderly
  Allergy, 2021
• Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
  New England Journal of Medicine, 2021
• Willingness of Long‐Term Care Staff to Receive a COVID ‐19 Vaccine: A Single State Survey
  Journal of the American Geriatrics Society, 2020
• Efficacy and safety of COVID-19 vaccines in older people
  Age and Ageing, 2020